NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

The current 1.2b common authorization could cover the 341m warrants, and is certainly sufficient for all non-management warrants.

What is not covered is mgmt and Board options, notably including the additional 200m options granted to themselves in the last quarter.

nwbo still has the full Preferred authorization available too, although convertibility and warrants mean this defers the common authorization issue rather than solves it.